Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Patients’ preferences for bone metastases treatments in France, Germany and the United Kingdom

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • الموضوع:
      2015
    • Collection:
      DI-fusion : dépôt institutionnel de l'Université libre de Bruxelles (ULB)
    • نبذة مختصرة :
      Results: The most important treatment attributes for patients across all three countries were time until first SRE, annual risk of renal complications and time until pain worsening. For these attributes, better levels of outcomes were significantly preferred to worse levels (p < 0.05). A 120-minutes infusion every 4 weeks was the least preferred mode of administration. Risk of ONJ was judged by patients in the UK and Germany to be the least important attribute. ; SCOPUS: ar.j ; info:eu-repo/semantics/published
    • File Description:
      1 full-text file(s): application/pdf
    • Relation:
      uri/info:doi/10.1007/s00520-014-2309-x; uri/info:scp/84919385191; https://dipot.ulb.ac.be/dspace/bitstream/2013/192346/3/doi_175973.pdf; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/192346
    • الدخول الالكتروني :
      http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/192346
      https://dipot.ulb.ac.be/dspace/bitstream/2013/192346/3/doi_175973.pdf
    • الرقم المعرف:
      edsbas.78A5AD0D